StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Amit Seth

BUYZydus Lifesciences Limited

byAmit SethHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via CNBC Awaaz.

Entry₹1,185.5Inferred
Target₹1,220
Total upside +2.91%
Stop loss₹1,160-2.15% risk
CMP₹1,203.922h ago
Active+1.55%+1.34%upside left 13d left
Follow Amit Seth for new calls(29% target hit, 130 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 3 other Swing calls on ZYDUSLIFESee 311 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Sept, 2:59 pm IST
6 supporting1 neutral1 opposing
Supports the BUY call (6)

Zydus Lifesciences says USFDA inspection at New Jersey office concludes with nil observations

NewsCnbc-Tv18·26 Sept · today

(opens in new tab)

The USFDA inspection of Zydus Lifesciences' USA office for pharmacovigilance and post-marketing systems concluded with no observations.

BSE · Company Update·26 Sept · today

(opens in new tab)

MACD above its signal line — bullish momentum

Technicals · macd·26 Sept · today

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·25 Sept · yesterday

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (1)

Zydus Lifesciences (NSE:ZYDUSLIFE): Why Did It Publish a Lost Share Certificate Notice?

NewsGoogle News·24 Sept · yesterday

(opens in new tab)
Weighs against the BUY call (1)

RSI at 71 — overbought territory

Technicals · rsi·26 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.